Open-Label, Fixed Sequence, Crossover Study To Estimate The Effect Of Multiple Dose Maraviroc On Single Dose Digoxin Pharmacokinetics In Healthy Subjects.
Phase of Trial: Phase IV
Latest Information Update: 06 Apr 2011
At a glance
- Drugs Digoxin; Maraviroc
- Indications Heart failure; HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Pfizer
- 15 Nov 2010 Additional lead trial centre and associate identified as reported by ClinicalTrials.gov.
- 23 Apr 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
- 23 Apr 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.